- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05951998
Frequency of h.Pylori in Children With Dyspeptic Symptoms
Frequency and Risk Factors of H.Pylori Infection in Children Presented by Dyspeptic Symptoms in Assiut University Children Hospital
The current work aim to:
Estimation of prevalence, Estimation of risk factors, Estimation of endoscopic picture of H. pylori infection in children presented with chronic or recurrent dyspeptic symptoms and/or non variceal hematemesis.
Study Overview
Status
Conditions
Detailed Description
Helicobacter pylori infection is a common problem in pediatric practice, it's an important cause of gastrointestinal pathology in children and its acquisition is related with poor socioeconomic conditions. H.pylori is a spiral, microaerophilic, gram-negative bacterium with four to six unipolar sheathed flagella.The human stomach, especially the antrum, is the most common reservoir of this agent. American board of orthodontists antibody blood group and Lewis blood-group antigen might expose cases to H. pylori infection, the most likely mode of transmission is fecal-oral or oral-oral. H.pylori infection is predominantly acquired during early childhood .
The majority of children with are asymptomatic although a percentage of the infected children develop H. pylori associated diseases such as iron deficiency anemia, B12 deficiency, chronic thrombocytopenic purpura. It can manifest with burning pain in the stomach, nausea, loss of appetite, bloating, weight loss.
Previous studies showed that geographic area, age, race, educational level, sanitation, and socioeconomic status are among the factors that influence the prevalence of H. pylori infection . No gender differences were found in the prevalence of H. pylori infection, while it was much higher among white people.
The overall prevalence of H. pylori infection in Egyptian school children was 72.38%. There was no significant difference in the prevalence of infection between boys and girls (73.80% vs. 70.34% respectively, or in the independent effect of sex by age. Of school children living in Sohag, 96.7% tested positive for H. pylori, compared with 81.3% of children from Giza and 61.9% from Cairo. Prevalence was also highest among children of low socio-economic class and decreased gradually among children of medium to high socio-economic class.
In a previous study conducted by Hunt et al., the prevalence of H. pylori was reported to be 48% among 2-4-year-old children in Ethiopia, while in Nigeria and Mexico it was 82% and 43%, respectively, among 5-9-year-old children..
The endoscopic findings in order of decreasing frequency in the Pediatric group were nodularity (93.0%), mucosal swelling (32.6%), spotty redness (25.6%), diffuse redness (18.6%), atrophy (9.3%), enlarged fold (4.7%), depressive erosion (4.7%), foveolar-hyperplastic polyp (2.3%), patchy redness (2.3%), red streak (2.3%), and raised erosion (2.3%).
Invasive and non-invasive tests could be used for diagnosis, while the gold standard is a biopsy specimen of gastrointestinal tract.
Triple therapy is considered to be the standard treatment for children. Proton pump inhibitor combined with two antibiotics has been shown to be very effective in clearing H. pylori from the stomach, it is recommended to treat with amoxicillin, clarithromycin and a proton pump inhibitor for 2 weeks.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mariam S Fayek
- Phone Number: 01277773806
- Email: romasmsmfayek@gmail.com
Study Contact Backup
- Name: Mariam S F
- Phone Number: 01277773806
- Email: romasmsmfayek@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children from age of 3 years to age of 18 years.
- Children presented with chronic or recurrent dyspeptic symptoms(epigastric pain, post prandial fullness, early satiety, bleaching, heart burn ,bloating ,flatulence ,regurgitation ,nausea ,vomiting and/or halitosis) and/or non variceal hematemesis.
Exclusion Criteria:
- Children less than 3 years and more than 18 years.
- Children with variceal hematemesis.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimation of frequency of H.pylori infection
Time Frame: Baseline
|
2.Estimation of prevalence of H.pylori infection 3.Estimation of risk factors of H.pylori infection 4.Estimation of endoscopic picture of H. pylori infection in children presented with chronic or recurrent dyspeptic symptoms and/or non variceal hematemesis. |
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gamal A Askar, Prof, Assiut University
- Principal Investigator: Ashraf M Elsaghier, Prof, Assiut University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H.pylori infection in children
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on H.Pylori Infection
-
Assiut UniversityNot yet recruitingH.Pylori Infection
-
Soonchunhyang University HospitalCompletedH.Pylori InfectionKorea, Republic of
-
Hamdard UniversityCompleted
-
Soonchunhyang University HospitalRecruiting
-
Soonchunhyang University HospitalCompleted
-
Soonchunhyang University HospitalCompleted
-
Dow University of Health SciencesRecruitingH.Pylori Infection | H.Pylori Eradication Rate | H. Pylori Gastrointestinal DiseasePakistan
-
Chinese University of Hong KongNot yet recruitingH.Pylori Infection
-
Javeriana UniversityUniversidad Nacional de ColombiaCompletedTherapy | H.Pylori Infection | CYP2C19 Polymorphism